NASDAQ:MYOK
Delisted
MyoKardia Stock News
$224.91
+0 (+0%)
At Close: May 27, 2022
Virtual Analyst and Investor Event to Review Data Planned for 4:30 p.m. EDT on March 30
Bank of Montreal Can Purchases 1,713 Shares of Myokardia Inc (NASDAQ:MYOK)
09:04am, Thursday, 19'th Mar 2020
Bank of Montreal Can boosted its position in Myokardia Inc (NASDAQ:MYOK) by 41.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,811 shares of the
Citigroup Inc. Has $1.06 Million Position in Myokardia Inc (NASDAQ:MYOK)
11:26am, Wednesday, 18'th Mar 2020
Citigroup Inc. lifted its position in shares of Myokardia Inc (NASDAQ:MYOK) by 46.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Here’s What We Think About MyoKardia, Inc.’s (NASDAQ:MYOK) CEO Pay
01:58pm, Tuesday, 17'th Mar 2020
Tassos Gianakakos has been the CEO of MyoKardia, Inc. (NASDAQ:MYOK) since 2013. First, this article will compare CEO...
Analysts Offer Insights on Healthcare Companies: Galmed Pharmaceuticals (GLMD) and MyoKardia (MYOK)
10:48am, Monday, 16'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galmed Pharmaceuticals (GLMD) and MyoKardia (MYOK) with
Analysts Offer Insights on Healthcare Companies: Galmed Pharmaceuticals (NASDAQ: GLMD) and MyoKardia (NASDAQ: MYOK)
10:47am, Monday, 16'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galmed Pharmaceuticals (
GLMD
–
Research Report
) and MyoKardia (
MYOK
–
Research Report
) with bul
Edited Transcript of MYOK earnings conference call or presentation 27-Feb-20 9:30pm GMT
01:40pm, Sunday, 15'th Mar 2020
Q4 2019 MyoKardia Inc Earnings Call
Edited Transcript of MYOK earnings conference call or presentation 27-Feb-20 9:30pm GMT
07:08am, Sunday, 15'th Mar 2020
Q4 2019 MyoKardia Inc Earnings Call
Myokardia Inc (NASDAQ:MYOK) Shares Sold by AlphaCrest Capital Management LLC
08:18am, Saturday, 14'th Mar 2020
AlphaCrest Capital Management LLC cut its stake in Myokardia Inc (NASDAQ:MYOK) by 26.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Oracle Corp (NYSE: ORCL) Q3 2020 Earnings Call Transcript | AlphaStreet
09:13am, Friday, 13'th Mar 2020
Good afternoon everyone and welcome to Oracle's third quarter fiscal year 2020 earnings conference call.
Analysts Anticipate Myokardia Inc (NASDAQ:MYOK) to Announce -$1.38 Earnings Per Share
08:30am, Friday, 13'th Mar 2020
Equities research analysts expect Myokardia Inc (NASDAQ:MYOK) to announce ($1.38) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have made est
Cytokinetics: Multiple Growth Catalysts Ahead In 2020
04:31pm, Wednesday, 11'th Mar 2020
Omecamtiv mecarbil program is the leading growth driver for Cytokinetics in 2020. CK-274 can emerge as a major drug in HCM indication. Investors must consider r
Weekly Analysts' Ratings Updates for Myokardia (MYOK)
07:24am, Wednesday, 11'th Mar 2020
Several analysts have recently updated their ratings and price targets for Myokardia (NASDAQ: MYOK): 3/5/2020 – Myokardia had its “buy” rating reaffirmed by analysts at Cowen Inc. They now have
3 Beaten-Down Biotech Stocks With Catalysts Just Around the Corner
05:45pm, Tuesday, 10'th Mar 2020
With the outbreak of the coronavirus, volatility has become a seemingly ever-present facet of the stock market. Since the end of February, the major U.S. indexes have experienced violent swings in eit
3 Beaten-Down Biotech Stocks With Catalysts Just Around the Corner
05:42pm, Tuesday, 10'th Mar 2020
With the outbreak of the coronavirus, volatility has become a seemingly ever-present facet of the stock market. Since the end of February, the major U.S.
